The current state of infectious disease: a clinical perspective on antimicrobial resistance.

L. E. Shay, A. G. Freifeld

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

The medical community is in the midst of a wake-up call. No longer can antimicrobial use be taken for granted. The overprescribing of antimicrobials has taken its toll and the consequence has been a precipitous increase in drug-resistant pathogens seen over the last decade. Pharmaceutical companies and researchers are no longer able to keep a step ahead of these resistant pathogens with new antimicrobial agents. The primary care clinician is now faced with complicated treatment issues for many infectious diseases that were once considered uncomplicated. The mechanisms leading to the development of antimicrobial resistance in bacteria is discussed in addition to an overview of the most common drug-resistant pathogens.

Original languageEnglish (US)
Pages (from-to)1-15; quiz 16-18
JournalLippincott's primary care practice
Volume3
Issue number1
StatePublished - Jan 1 1999

Fingerprint

Communicable Diseases
Pharmaceutical Preparations
Anti-Infective Agents
Primary Health Care
Research Personnel
Bacteria

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The current state of infectious disease : a clinical perspective on antimicrobial resistance. / Shay, L. E.; Freifeld, A. G.

In: Lippincott's primary care practice, Vol. 3, No. 1, 01.01.1999, p. 1-15; quiz 16-18.

Research output: Contribution to journalReview article

@article{db57a596a3d241018efe932ff5a30211,
title = "The current state of infectious disease: a clinical perspective on antimicrobial resistance.",
abstract = "The medical community is in the midst of a wake-up call. No longer can antimicrobial use be taken for granted. The overprescribing of antimicrobials has taken its toll and the consequence has been a precipitous increase in drug-resistant pathogens seen over the last decade. Pharmaceutical companies and researchers are no longer able to keep a step ahead of these resistant pathogens with new antimicrobial agents. The primary care clinician is now faced with complicated treatment issues for many infectious diseases that were once considered uncomplicated. The mechanisms leading to the development of antimicrobial resistance in bacteria is discussed in addition to an overview of the most common drug-resistant pathogens.",
author = "Shay, {L. E.} and Freifeld, {A. G.}",
year = "1999",
month = "1",
day = "1",
language = "English (US)",
volume = "3",
pages = "1--15; quiz 16--18",
journal = "Lippincott's primary care practice",
issn = "1088-5471",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - The current state of infectious disease

T2 - a clinical perspective on antimicrobial resistance.

AU - Shay, L. E.

AU - Freifeld, A. G.

PY - 1999/1/1

Y1 - 1999/1/1

N2 - The medical community is in the midst of a wake-up call. No longer can antimicrobial use be taken for granted. The overprescribing of antimicrobials has taken its toll and the consequence has been a precipitous increase in drug-resistant pathogens seen over the last decade. Pharmaceutical companies and researchers are no longer able to keep a step ahead of these resistant pathogens with new antimicrobial agents. The primary care clinician is now faced with complicated treatment issues for many infectious diseases that were once considered uncomplicated. The mechanisms leading to the development of antimicrobial resistance in bacteria is discussed in addition to an overview of the most common drug-resistant pathogens.

AB - The medical community is in the midst of a wake-up call. No longer can antimicrobial use be taken for granted. The overprescribing of antimicrobials has taken its toll and the consequence has been a precipitous increase in drug-resistant pathogens seen over the last decade. Pharmaceutical companies and researchers are no longer able to keep a step ahead of these resistant pathogens with new antimicrobial agents. The primary care clinician is now faced with complicated treatment issues for many infectious diseases that were once considered uncomplicated. The mechanisms leading to the development of antimicrobial resistance in bacteria is discussed in addition to an overview of the most common drug-resistant pathogens.

UR - http://www.scopus.com/inward/record.url?scp=0032611201&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032611201&partnerID=8YFLogxK

M3 - Review article

C2 - 10214199

AN - SCOPUS:0032611201

VL - 3

SP - 1-15; quiz 16-18

JO - Lippincott's primary care practice

JF - Lippincott's primary care practice

SN - 1088-5471

IS - 1

ER -